Skip to main content
graph.swiss
EvoNext Holdings SA

EvoNext Holdings SA

2.22 CHF-0.06 (-2.63%)
XSWX:EVEMarket Closed
ListedCHF16MHealthcareBiotechnology49 employees

Company Profile

Legal NameEvoNext Holdings SA
CEOMr. Ahmed Khaled El-Hoshy
HeadquartersDuggingerstrasse 23
Phone41 61 485 2000
Employees (FTE)49
SectorHealthcare
IndustryBiotechnology

Business Description

EvoNext Holdings SA is a Switzerland-based biotechnology company that develops and commercializes nature-based ingredients. It leverages advanced technology platforms combining biology and precision fermentation to produce sustainable alternatives for use in flavorings, fragrances, nutritional and healthcare products, cosmetics, and other sectors. The company focuses on novel food, nutritional, and healthcare ingredients, offering tailored technology services to clients across various industries. EvoNext Holdings SA emphasizes enhancing the efficiency and scalability of producing high-value, nature-identical ingredients that meet consumer demand for clean-label and eco-friendly solutions. Headquartered in Reinach, Switzerland, it operates within the biotechnology and medical research field, contributing to innovation in health protection, personal care, and food applications by providing high-purity, plant-derived compounds through biotechnological processes.

Profitability & Growth

Profitability

Profit Margin+0.00%
Operating Margin+0.00%
Return on Equity (TTM)-10.41%
Return on Assets (TTM)-4.41%

Recent Year-End

Diluted EPS-0.09

Balance Sheet Snapshot

Total Cash (MRQ)

5.9M

Current Ratio (MRQ)

8.31

Book Value / Share

0.82

Stock Statistics

Shares Outstanding7.2M
Avg Volume (10d)14.1K
Avg Volume (90d)31.9K
% Held by Insiders+41.00%
% Held by Institutions+2.04%

Valuation

Market Cap16.0M
Enterprise Value9.5M
Trailing P/E7.82
Forward P/E-0.88
PEG Ratio-0.88
Price / Book (MRQ)2.67
EV / EBITDA-19.95

Price Summary

52-Week Low0.75
52-Week High2.74
50-Day MA1.70
200-Day MA1.07
Beta-0.05

Dividends

Dividend Date2017-10-31